Bio-Rad Laboratories Total Liabilities

As of the most recent data (June 2026), BIO.B shows a total liabilities of $3.1B. That compares with $3.1B in the prior-year period — down 0.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIO.B's total liabilities is now $3.1B (was $3.1B) — a 0.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bio-Rad Laboratories is outperforming or lagging.

Tracking BIO.B's total liabilities over time shows whether Bio-Rad Laboratories is scaling, shrinking, or reshaping that part of the business. The current reading is $3.1B That compares with $3.1B in the prior-year period — down 0.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Bio-Rad Laboratories's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $3.1B) with ownership activity and broader fundamentals.

Bio-Rad Laboratories's total liabilities is $3.1B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.